BA
VIVS

BKS Advisors’s VivoSim Labs VIVS Stock Holding History

BKS Advisors’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$13K Buy
+54
New +$13.6K 0.01% 208

Other funds holding VIVS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BKS Advisors's VIVS Position: Q1 2019 in Review

BKS Advisors opened a new position in VivoSim Labs (VIVS) in Q1 2019: 54 shares worth $13K. The stake represents 0.01% of the portfolio and ranks #208 among its holdings.

109 funds tracked by Wall St. Rank hold VIVS as of Q1 2019.

  • BKS Advisors held 54 shares of VivoSim Labs worth $13K as of Q1 2019.
  • VivoSim Labs was a new BKS Advisors position in Q1 2019.
  • VivoSim Labs made up 0.01% of BKS Advisors's portfolio in Q1 2019, its #208 holding.
  • 109 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.